Tag: Galectin Therapeutics Inc.

Company’s 36-month beta value is 0.69.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 0 as

The stock of Galectin Therapeutics Inc (GALT) has gone up by 56.07% for the week, with a 79.33% rise in the past month and a

The stock of Galectin Therapeutics Inc (GALT) has gone up by 20.25% for the week, with a 43.22% rise in the past month and a

GALT has 36-month beta value of 0.83. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,”